https://www.selleckchem.com/pr....oducts/eribulin-mesy
Importance QT-prolonging medications (QTPMs) are a reported risk factor for sudden cardiac death (SCD) when defined by consensus criteria that presume an arrhythmic cause. The effect of QTPM on autopsy-defined sudden arrhythmic death (SAD) is unknown. Objective To evaluate the association between QTPM and autopsy-defined SAD vs nonarrhythmic cause of sudden death. Design, Setting, and Participants This prospective countywide case-control study included World Health Organization-defined (presumed) SCD cases who underwent
Like
Comment
Share
